Transfer from: ammonia-based observation The Chinese pharmaceutical industry at the beginning of the twenty-first century did not have a good blueprint for the top, nor did it have so many analysts and consulting firms report. Even overseas, China is an innovative drug indifference. In recent years, China’s innovative drug industry, supported by a wide range of policies, capital and so forth, has reached an excellent acceleration point. China’s innovative pharmaceutical industry is also movin...